Schedule A Demo

Dr. Gorman Discusses FDA Approval of New Breast Cancer Medications

June 16, 2020
Download as PDF Single Release RSS Feed
Facebook Twitter Google Digg Reddit LinkedIn Email

Dr. Valerie Gorman, a breast cancer surgeon in Waxahachie, Texas. She recently released an article discussing the FDA’s accelerated approval of two new breast cancer medications, Todelvy and Tukysa. These two drugs were able to be advanced through the approval process in an accelerated rated due to the current COVID-19 pandemic, though each must be taken under specific conditions. Testing on these medications will continue so that clinical data can continue to be gathered before full approval can be met.

Dr. Gorman took the time to explain each medication’s function, what it targets, and what it has been shown to effect. She also explains the common side effects of these drugs for anyone who may take them.

Tukysa is intended for patients with metastatic, HER2-positive breast cancers. It can only be given on the condition that at least one other “anti-HER2-based treatment geared towards metastasis” has already been attempted. While further clinical trials are being attempted, Tukysa has been granted accelerated approval to help those with advanced cases of such an extreme form of cancer.

Trodelvy targets metastatic breast cancers and, in previous trials, had a “response rate [of] 33%, and 55.6% of those responders maintained their response at least six months”. This medication can be taken on the condition that at least two treatments have been previously pursued for their metastatic cancer.

Dr. Gorman is board certified by the American Board of Surgery and serves as both the Medical Director of Surgical Services and Chief of Surgery at Baylor Scott & White Medical Center in Waxahachie. Her goal is to keep her patients informed and to always offer her patients an informed, personalized approach to breast cancer treatment.



SOURCE: Press Advantage [Link]

Download as PDF Single Release RSS Feed
Facebook Twitter Google Digg Reddit LinkedIn Email

About Texas Breast Center:

Valerie J. Gorman, MD, FACS, is a surgeon of oncology and diseases of the breast. She is board certified by the American Board of Surgery and serves as Chief of Surgery and Medical Director of Surgical Services at Baylor Scott & White Medical Center.

Contact Texas Breast Center:

Greg Gorman
2460 N, I-35E Suite 215, Waxahachie, TX 75165
214-912-5195

Social Media:

Additional News Releases From Texas Breast Center:

August 04, 2021Texas Breast Center Releases Article on Breast Cancer in Men

April 15, 2021Texas Breast Center Releases Article on the History of Breast Cancer

October 23, 2020Dr. Gorman Discusses Breast Cancer Risks

August 25, 2020Dr. Gorman Released Article on Breast Density

June 30, 2020New Article Released on Defining Breast Cancer

June 16, 2020Dr. Gorman Discusses FDA Approval of New Breast Cancer Medications

June 01, 2020Dr. Gorman and Texas Breast Center Share Their COVID Prevention Efforts

January 30, 2020Dr. Valerie Gorman Answers More Questions on Mastectomies

November 27, 2019Dr. Gorman Teams Up with Plastic Surgeon to Give Patients Best Cosmetic Results After Breast Cancer Surgery

November 14, 2019Texas Breast Center Releases Tips on Breast Self-Exams for Breast Cancer Awareness Month